Literature DB >> 2888950

Explanation for potency of repeated oral doses of morphine?

G W Hanks1, P J Hoskin, G W Aherne, P Turner, P Poulain.   

Abstract

Morphine given by injection is the standard by which all other strong analgesics are measured, but when given orally in single doses it is a poor analgesic. With repeated oral administration it becomes very effective and it may be that on repeated dosage active metabolites, particularly morphine-6-glucuronide, account for much of the analgesic activity. Enterohepatic circulation may also contribute to the maintenance of blood and tissue levels of morphine and its metabolites in chronic use.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888950     DOI: 10.1016/s0140-6736(87)91083-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

1.  Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients.

Authors:  T J Wilkinson; B A Robinson; E J Begg; S B Duffull; P J Ravenscroft; J J Schneider
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Contribution to variability in response to opioids.

Authors:  Geoffrey W Hanks; Colette Reid
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

Review 3.  Strong opioids in pediatric palliative medicine.

Authors:  Richard D W Hain; Angela Miser; Mary Devins; W Hamish B Wallace
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

4.  Heroin intoxication: the relation between plasma morphine concentration and clinical state at admission.

Authors:  J Gutierrez-Cebollada; J Camí; R de la Torre
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

6.  Co-proxamol is effective in chronic pain.

Authors:  G W Hanks; K Forbes
Journal:  BMJ       Date:  1998-06-27

7.  Volume of hydration in terminal cancer patients.

Authors:  E Bruera; M Belzile; S Watanabe; R L Fainsinger
Journal:  Support Care Cancer       Date:  1996-03       Impact factor: 3.603

Review 8.  Enterohepatic circulation of opioid drugs. Is it clinically relevant in the treatment of cancer patients?

Authors:  G W Hanks; P J Wand
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

9.  Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry.

Authors:  Michael G Feasel; Ariane Wohlfarth; John M Nilles; Shaokun Pang; Robert L Kristovich; Marilyn A Huestis
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

10.  Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.

Authors:  J Hasselström; J Säwe
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.